Abstract: A rechargeable battery jump starting device and a rechargeable battery assembly for use in the portable rechargeable battery jump starting device. The portable rechargeable battery jump starting device maximizes the power conducted from the rechargeable battery assembly to a battery being jump started.

Abstract: Provided is a medical device formed entirely from or formed partially from a polymer, e.g., a polysaccharide such as chitosan. In some embodiments, the medical device may be formed as a tubular member formed from a sheet of a chitosan material. This chitosan tube may be used to wrap around tissue, such as a nerve or tendon to help with the regeneration or healing process of the nerve or tendon, as applicable.

Abstract: A jump starting apparatus configured for jump starting a vehicle battery includes a rechargeable battery, a first battery cable having a first battery terminal connector for connecting the jump starting apparatus to a first battery terminal of the vehicle battery, a second battery cable having a second battery terminal connector for connecting the jump starting apparatus to a second battery terminal of the vehicle battery, a first conductor bar or plate connecting a conductor of the first battery cable to a first tab or terminal of the rechargeable battery, and a safety control system or circuit configured for detecting when the jump starting apparatus is properly connected to the vehicle battery and then switching on power from the rechargeable battery to the vehicle battery only when the jump starting apparatus is properly connected to the vehicle battery.

Abstract: The present disclosure encompasses engineered meganucleases that bind and cleave recognition sequences within a dystrophin gene. The present disclosure also encompasses methods of using such engineered meganucleases to make genetically modified cells. Further, the disclosure encompasses pharmaceutical compositions comprising engineered meganuclease proteins, or polynucleotides encoding engineered meganucleases of the disclosure, and the use of such compositions for the modification of a dystrophin gene in a subject, or for treatment of Duchenne Muscular Dystrophy.

Abstract: A rechargeable battery assembly includes a rechargeable battery having a positive terminal and a negative terminal, and a rigid electrically conductive frame electrically connected to at least one of the positive terminal or the negative terminal of the rechargeable battery. The rigid electrically conductive frame is bent along multiple axes and includes a plurality of conductive frame members that are mechanically coupled together. The rigid electrically conductive frame surrounds the rechargeable battery on at least five sides, thereby providing structural stability to the rechargeable battery assembly during storage and use.

Abstract: An apparatus for jump starting a vehicle includes a handheld booster device comprising a rechargeable battery pack, a control circuit, a power switch, and an output port, wherein the control circuit detects when it is safe to couple the handheld booster device to the vehicle's battery and connects the rechargeable battery pack to the output port thru the power switch; and a jumper cable device comprising a plug and a pair of cables integrated with the plug, the plug being configured to connect to the output port of the handheld booster device in a specific orientation.

Abstract: Provided is a medical device formed entirely from or formed partially from a polymer, e.g., a polysaccharide such as chitosan. In some embodiments, the medical device may be formed as a tubular member formed from a sheet of a chitosan material. This chitosan tube may be used to wrap around tissue, such as a nerve or tendon to help with the regeneration or healing process of the nerve or tendon, as applicable.

Abstract: A circumferential nerve cutter is described herein. The nerve cutter holds a nerve in tension while circumferentially constraining the side of the nerve being retained in a manner that prevents flattening or crushing. A head of the nerve cutter separates the preserved side from the portion of the nerve being cut that is being removed. The head includes a cutting slot configured to accommodate an off-the-shelf scalpel blade, while ensuring that the blade remains approximately square preventing obliquity of resultant cut. The side of the head that interfaces with the preserved side of the nerve is configured to prevent and/or inhibit the nerve from moving radially to its axis while being cut.

Abstract: A processing device receives a first cluster management operation request, wherein the first cluster management operation request is for a deployment operation of a first cluster and comprises a cluster template, a specified number of nodes to deploy and a configuration. The processing device determines a plurality of constraints from at least one of the cluster template or the configuration. The processing device deterministically solves for and outputs a first cluster layout comprising the specified number of nodes, each of the specified number of nodes comprising a hardware type, an image type and one or more services, wherein the first cluster layout satisfies the plurality of constraints.

Abstract: A processing device receives a first cluster management operation request, wherein the first cluster management operation request is for a deployment operation of a first cluster and comprises a cluster template, a specified number of nodes to deploy and a configuration. The processing device determines a plurality of constraints from at least one of the cluster template or the configuration. The processing device deterministically solves for and outputs a first cluster layout comprising the specified number of nodes, each of the specified number of nodes comprising a hardware type, an image type and one or more services, wherein the first cluster layout satisfies the plurality of constraints.